To provide infectious disease physicians and other healthcare professionals interested in infectious disease with up-to-date information on the treatment of patients with life-threatening bacterial and fungal infections.
This activity is designed for infectious disease physicians and other healthcare professionals interested in infectious disease. No prerequisites required.
The Johns Hopkins University School of Medicine and University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
- Describe the epidemiology of zygomycosis infections and outline an approach to their prevention and treatment.
- Integrate evidence-based practices into the management of patients with fungal infections.
- Develop clinical strategies for the management of patients with hospital-acquired pneumonia and diabetic foot infection, incorporating principles from published treatment guidelines.
- Contain the resistance epidemic by implementing policies for the judicious use of antibiotic therapy.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This program is approved for 2.5 hours (0.25 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmacy Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE program #064-000-05-212-H01.
The estimated time to complete this educational activity: 2.5 hours.
Release date: June 15, 2006. Expiration date: June 15, 2008.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
This program is supported by an educational grant from Merck and Company.